HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia

被引:26
|
作者
Amenomori, Misato [1 ]
Mukae, Hiroshi [1 ,4 ]
Sakamoto, Noriho [1 ]
Kakugawa, Tomoyuki [1 ]
Hayashi, Tomayoshi [2 ]
Nara, Atsuko [1 ]
Hara, Shintaro [1 ]
Fujita, Hanako [1 ]
Ishimoto, Hiroshi [1 ]
Ishimatsu, Yuji [1 ]
Nagayasu, Takeshi [3 ]
Kohno, Shigeru [1 ]
机构
[1] Nagasaki Univ, Dept Internal Med 2, Sch Med, Nagasaki 8528501, Japan
[2] Nagasaki Univ Hosp, Dept Pathol, Nagasaki 8528501, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Div Surg Oncol, Dept Translat Med Sci, Nagasaki 8528501, Japan
[4] Univ Occupat & Environm Hlth, Dept Resp Dis, Sch Med, Yahata Nishi Ku, Fukuoka 8078555, Japan
关键词
Collagen vascular disease; Fibrotic interstitial pneumonia; Fibrotic nonspecific interstitial pneumonia; Heat shock protein 47; Usual interstitial pneumonia; IDIOPATHIC PULMONARY-FIBROSIS; PROGNOSTIC-SIGNIFICANCE; HISTOLOGIC PATTERN; EXPRESSION; FEATURES; HEAT-SHOCK-PROTEIN-47;
D O I
10.1016/j.rmed.2010.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The histopathologic pattern is currently the most important prognostic marker for idiopathic interstitial pneumonia (IIP). However, more highly sensitive markers are now required. Heat shock protein (HSP) 47, a collagen-specific molecular chaperone, is involved in the processing and/or secretion of procollagens, and it has been demonstrated that HSP47 expression is significantly higher in the lung specimens of idiopathic UIP than in UIP associated with collagen vascular diseases (CVD). However, its expression in nonspecific interstitial pneumonia (NSIP), the other common pathological pattern of IIP, has not been well investigated. Therefore, the association between lung fibroblast HSP47 expression and prognosis in fibrotic NSIP was evaluated. Methods: Surgical lung biopsy specimens of 63 patients [idiopathic fibrotic NSIP = 19, fibrotic NSIP associated with CVD = 9, idiopathic UIP = 26, and UIP associated with CVD = 9] were reviewed, and a score for lung fibroblast HSP47 expression was assigned. These patients' clinical features and survival were also analyzed. Results: There was no significant difference in HSP47 expression between idiopathic fibrotic NSIP and fibrotic NSIP associated with CVD. The idiopathic fibrotic NSIP patients with higher HSP47 expression levels in their lung specimens had a poorer prognosis than patients with lower HSP47 expression levels. Conclusions: The present results suggest that lung fibroblast HSP47 expression may be a useful new prognostic marker for idiopathic fibrotic nonspecific interstitial pneumonia. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:895 / 901
页数:7
相关论文
共 50 条
  • [1] Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia
    Kakugawa, T
    Mukae, H
    Hayashi, T
    Ishii, H
    Nakayama, S
    Sakamoto, N
    Yoshioka, S
    Sugiyama, K
    Mine, M
    Mizuta, Y
    Kohno, S
    RESPIRATORY RESEARCH, 2005, 6 (1):
  • [2] Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
    Tomoyuki Kakugawa
    Hiroshi Mukae
    Tomayoshi Hayashi
    Hiroshi Ishii
    Seiko Nakayama
    Noriho Sakamoto
    Sumako Yoshioka
    Kanako Sugiyama
    Mariko Mine
    Yohei Mizuta
    Shigeru Kohno
    Respiratory Research, 6
  • [3] High serum concentrations of autoantibodies to HSP47 in nonspecific interstitial pneumonia compared with idiopathic pulmonary fibrosis
    Kakugawa T.
    Yokota S.-I.
    Mukae H.
    Kubota H.
    Sakamoto N.
    Mizunoe S.
    Matsuoka Y.
    Kadota J.-I.
    Fujii N.
    Nagata K.
    Kohno S.
    BMC Pulmonary Medicine, 8 (1)
  • [4] Emerging indicators of survival in cellular and fibrotic nonspecific interstitial pneumonia
    Carbone, Roberto G.
    Privitera, Vito
    Montanaro, Fabio
    Monselise, Assaf
    Ghio, Riccardo
    CHEST, 2007, 132 (04) : 457S - 457S
  • [5] Small molecule inhibitor of HSP47 prevents pro-fibrotic mechanisms of fibroblasts in vitro
    Miyamura, Takuto
    Sakamoto, Noriho
    Kakugawa, Tomoyuki
    Taniguchi, Hirokazu
    Akiyama, Yoshiko
    Okuno, Daisuke
    Moriyama, Sakiko
    Hara, Atsuko
    Kido, Takashi
    Ishimoto, Hiroshi
    Yamaguchi, Hiroyuki
    Miyazaki, Taiga
    Obase, Yasushi
    Ishimatsu, Yuji
    Tanaka, Yoshimasa
    Mukae, Hiroshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 530 (03) : 561 - 565
  • [6] Nonspecific interstitial pneumonia: A spectrum of cellular and fibrotic interstitial pneumonia.
    Travis, WD
    Matsui, K
    Moss, J
    Ferrans, VJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A65 - A65
  • [7] HSP47: a potential target for fibrotic diseases and implications for therapy
    Bellaye, Pierre-Simon
    Burgy, Olivier
    Bonniaud, Philippe
    Kolb, Martin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (01) : 49 - 62
  • [8] Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia
    Jegal, Y
    Kim, DS
    Shim, TS
    Lim, CM
    Do Lee, S
    Koh, Y
    Kim, WS
    Kim, WD
    Lee, JS
    Travis, WD
    Kitaichi, M
    Colby, TV
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (06) : 639 - 644
  • [9] Clinical characteristics and prognosis of fibrotic nonspecific interstitial pneumonia
    Cho, Hyun Kyu
    Yoo, Hongseok
    Wi, Seungbum
    Lee, Kyung Soo
    Chung, Myung Jin
    Han, Joungho
    Chung, Man Pyo
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] Statin-induced fibrotic nonspecific interstitial pneumonia
    Lantuejoul, S
    Brambilla, E
    Brambilla, C
    Devouassoux, G
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) : 577 - 580